To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products

NACompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

August 30, 2019

Primary Completion Date

November 29, 2019

Study Completion Date

November 29, 2019

Conditions
Skin Care
Interventions
OTHER

Serum

Participants will be topically applied serum to the dorsum, under a semi-occlusive patch (0.02 milliliters per centimeters square \[mL/cm\^2\] of serum in an individual cell of patch)

OTHER

Lotion

Participants will be topically applied lotion to the dorsum, under a semi-occlusive patch (0.02mL/cm\^2 of lotion in an individual cell of patch)

OTHER

Cream

Participants will be topically applied cream to the dorsum, under a semi-occlusive patch (0.02mL/cm\^2 of cream in an individual cell of patch)

OTHER

Normal Saline

Participants will be topically applied normal saline to the dorsum, under a semi-occlusive patch (0.02mL/cm\^2 of normal saline in an individual cell of patch)

Trial Locations (1)

13084-791

GSK Investigational Site, Campinas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT04007159 - To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products | Biotech Hunter | Biotech Hunter